Lv3
210 积分 2024-05-27 加入
Lung cancer
21天前
已完结
Albumin Nanoparticle-Based Drug Delivery Systems
21天前
已完结
Analysis of nanoparticle delivery to tumours
21天前
已完结
Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management
21天前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
21天前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
21天前
已完结
Construction of chitooligosaccharide-based nanoparticles of pH/redox cascade responsive for co-loading cyclosporin A and AZD9291
3个月前
已完结
Development and Optimization of Osimertinib-loaded Biodegradable Polymeric Nanoparticles Enhance In-vitro Cytotoxicity in Mutant EGFR NSCLC Cell Models and In-vivo Tumor Reduction in H1975 Xenograft Mice Models
3个月前
已完结
Covalent Binding Mechanism of Furmonertinib and Osimertinib With Human Serum Albumin
3个月前
已完结
皖公网安备34019202002308
